Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells. PLoS One. 2013; 8(7):e66987.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.